Volume Alert - PAH 25.15 Platform Specialty Products Corp.

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - PAH 25.15 Platform Specialty Products Corp. $PAH Hit a high today of 25.42 Closing the day 10:30 at 25.15 +0.14 +0.56% With a day low of 24.70 and a total volume of 2,877,906.

PAH Recent Posts: http://investorshangout.com/Platform-Specialt...PAH-62519/

PAH Platform Specialty Products Corp. Recent Headline News

Platform Specialty Products Corporation Announces Pricing of a $350 Million Public Offering of Common Stock
GlobeNewswire - Wed Nov 12, 7:00AM CST
Platform Specialty Products Corporation (NYSE AH) ("Platform" today announced the pricing of an underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $24.50 per share. The gross proceeds to Platform from this offering are expected to be approximately $350 million, before deducting underwriting discounts and commissions and offering expenses payable by Platform. Platform has granted to the underwriters a 30-day option to purchase an additional 2,145,000 shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform. The offering is expected to close on or about November 17, 2014, subject to customary closing conditions.
PAH: 25.10 (+0.09)

Monitoring Avante Logixx Results: Under Promise, Over Deliver
Unconventional Capital Wisdom - at Seeking Alpha - Tue Nov 11, 10:22AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products expects USD350m from planned public offering
M2 - Tue Nov 11, 6:12AM CST
Specialist chemicals company Platform Specialty Products (NYSE AH) reported on Monday that it intends to start its USD350m public offering of common shares.
PAH: 25.10 (+0.09)

Platform Specialty Products Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Mon Nov 10, 3:42PM CST
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Platform Specialty Products Corp was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny Technologies,...
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Launch of Public Offering of Common Stock
GlobeNewswire - Mon Nov 10, 6:12AM CST
Platform Specialty Products Corporation (NYSE AH) ("Platform" today announced that it has commenced a $350 million underwritten public offering of shares of its common stock. In connection with the offering, Platform intends to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. All of the shares of common stock to be sold in the offering are to be sold by Platform.
PAH: 25.10 (+0.09)

These Six Stocks Are Driving Bill Ackman's Extraordinary 2014 Run
at The Street - Fri Nov 07, 12:01PM CST
It's been a banner year for billionaire hedge fund magnate Bill Ackman -- especially considering just a handful of companies are propelling his big 2014 run.
AGN: 196.88 (+1.54), VRX: 130.49 (+0.46), HHC: 147.10 (+0.07), PAH: 25.10 (+0.09), CP: 209.33 (-0.68), APD: 134.56 (-0.36), BKW: 31.94 (-0.44)

Paul J. Collins Joins Centerview Partners
PR Newswire - Thu Nov 06, 8:00AM CST
Centerview Partners, a leading independent investment banking and advisory firm, announced today that Paul J. Collins has joined the firm as a partner in New York. Mr. Collins brings over 25 years of investment banking experience with deep expertise in chemicals and will enhance Centerview's capabilities in the sector.
BX: 31.89 (+0.27), EMN: 83.45 (-0.88), MRD: 22.94 (-0.75), PAH: 25.10 (+0.09), PPG: 203.48 (-1.78), DOW: 49.99 (+0.47)

Platform Specialty's (PAH) CEO Dan Leever on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 11:42AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products beats by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 7:10AM CST

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Third Quarter 2014 Financial Results
GlobeNewswire - Wed Nov 05, 7:00AM CST
- Net sales of $197 million, up 4.4% organically
PAH: 25.10 (+0.09)

Chemtura Completes Sale of Its Agrochemicals Business to Platform Specialty Products Corporation
GlobeNewswire - Mon Nov 03, 5:30PM CST
Chemtura Corporation (NYSE:CHMT) (Euronext Paris:CHMT) ("Chemtura" today announced that it has completed the sale of its agrochemicals business, Chemtura AgroSolutions, to Platform Specialty Products Corporation (NYSE AH) ("Platform" , a global specialty chemicals company, for approximately $1 billion, consisting of $950 million in cash and 2 million shares of Platform's common stock. The purchase price is subject to customary post-closing adjustments.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products Corporation Closes Acquisition of Chemtura AgroSolutions Business and Syndicated $405 Million of Term Loans Facility
GlobeNewswire - Mon Nov 03, 5:27PM CST
- Transaction expected to be immediately accretive to Platform's adjusted earnings, pre-synergies
PAH: 25.10 (+0.09)

Chemtura: A High-Potential Specialty Chemicals Producer
Daniel Lynch - at Seeking Alpha - Fri Oct 24, 3:51PM CDT

ASH: 112.28 (-0.44), GE: 26.43 (+0.05), PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform Specialty Products: The Architect And The Builder
Unconventional Capital Wisdom - at Seeking Alpha - Thu Oct 23, 5:15AM CDT

PAH: 25.10 (+0.09)

Why Platform Specialty Products (PAH) Stock Is Gaining Today
at The Street - Mon Oct 20, 2:17PM CDT
Platform Specialty Products (PAH) shares are climbing after the company announced it was purchasing Arysta LifeScience for $3.5 billion.
PAH: 25.10 (+0.09)

Platform Specialty to buy Arysta for $3.51 billion
AP - Mon Oct 20, 9:35AM CDT
NEW YORK (AP) — Platform Specialty Products Corp. said Monday that it will spend about $3.51 billion to buy rival chemical maker Arysta LifeScience Ltd. to diversify its product offerings.
PAH: 25.10 (+0.09)

Permira Books $3.5 Billion Exit From Ireland-based Arysta LifeScience
at The Street - Mon Oct 20, 9:06AM CDT
Sale to Martin Franklin's chemicals rollup Platform Specialty Products provides the London firm with a 1.7 times return on investment.
PAH: 25.10 (+0.09), CHMT: 23.51 (+0.03)

Platform to buy chemicals maker Arysta for $3.51B
Seeking Alpha - at Seeking Alpha - Mon Oct 20, 7:06AM CDT

PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Announces Preliminary Third Quarter Financial Results Record Q3 Adjusted EBITDA
GlobeNewswire - Mon Oct 20, 6:15AM CDT
- Net sales expected to be approximately $195 million to $197 million
PAH: 25.10 (+0.09)

Platform Specialty Products Corporation Signs Definitive Agreement to Acquire Arysta LifeScience Limited for Approximately $3.51 Billion
GlobeNewswire - Mon Oct 20, 6:14AM CDT
- Acquisition expected to be immediately accretive to Platform's adjusted earnings per share, pre-synergies
PAH: 25.10 (+0.09)

Element Solutions Inc. (ESI) Stock Research Links

ESI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading